Sigma-Aldrich Q1 Earnings Top, Backs View - Analyst Blog


Shutterstock photo

Lab chemical and life sciences company Sigma-Aldrich ( SIAL ) posted higher profits in first-quarter 2014 as increased sales across Applied and SAFC Commercial segments offset a decline in its larger research business, which was hurt by harsh winter weather.

The Missouri-based company's profit, as reported, moved up roughly 3% year over year in the reported quarter to $126 million or $1.05 per share from $122 million or $1.01 per share a year ago.

Barring restructuring charges, earnings were $1.06 per share in the quarter, topping the Zacks Consensus Estimate of $1.03.

Revenues and Margins

Sales for the quarter went up 2% year over year to $689 million, but missed the Zacks Consensus Estimate of $695 million. Organic sales gain in the quarter was 3%, while divestitures had an unfavorable impact of 1%.

Operating income rose roughly 5% year over year to $174 million. Adjusted operating margin for the reported quarter was 25.4%, up from 24.6% recorded a year ago, aided by favorable impact of the company's global supply gain initiatives.

Segment Highlights

Research Chemicals division's sales fell 1% year over year to $359 million in the quarter. The division was affected by bad weather that led to closure of research labs by many of Sigma-Aldrich's customers. Gains were witnessed across Europe, Middle East and Africa (EMEA) and Latin America while sales fell in the U.S. on weak academic spending.

Applied unit's sales rose 8% (7% organically) to $171 million. The gain was driven by high single-digits rise on an organic basis in diagnostics and testing business. Sales increased in the mid single-digits in the industrial business.

Sales from the SAFC Commercial segment went up 3% to $159 million. Sales rose in the low single-digits organically in life science products business while life science services saw a double-digit rise on gains in biopharma services. However, Hitech sales declined in the low single-digits on pricing pressure.


Sigma-Aldrich exited the quarter with cash and cash equivalents of $727 million, up 54% year over year. Long-term debt was flat year over year at $300 million. Debt-to-capital ratio was 10% as of Mar 31, 2014, compared with 13% as of Mar 31, 2013. Operating cash flow rose around 12% year over year to $172 million in the quarter.

Sigma-Aldrich repurchased 900,000 shares during the reported quarter for $85 million. It expects to continue to buyback shares to offset dilution associated with stock-based compensation.


Sigma-Aldrich backed its sales, earnings and cash flow guidance for 2014.  The company continues to expect adjusted earnings per share in the range of $4.30 to $4.40. The current corresponding Zacks Consensus Estimate is $4.36.

Moreover, the company envisions low-to-mid single-digit overall organic sales gain in 2014. It continues sees low-to-mid single-digit gain in its Research Chemicals unit. Sales in Applied and SAFC Commercial divisions are expected to rise in the mid-single digits.

Operating cash flow for 2014 has been projected to exceed $600 million. Free cash flow for the year has been forecast to exceed $475 million Capital expenditures are expected to be around $130 million for 2014. Adjusted operating income margin has been projected to increase by roughly 50 basis points.

Sigma-Aldrich is a Zacks Rank #3 (Hold) stock.

Other companies in the specialty chemicals space worth considering are Globe Specialty Metals, Inc. ( GSM ), International Flavors & Fragrances Inc. ( IFF ) and Rockwood Holdings, Inc. ( ROC ). All of them carry a Zacks Rank #2 (Buy).

GLOBE SPECIALTY (GSM): Free Stock Analysis Report

INTL F & F (IFF): Free Stock Analysis Report

ROCKWOOD HLDGS (ROC): Free Stock Analysis Report

SIGMA ALDRICH (SIAL): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Business , Earnings , Stocks
More Headlines for: GSM , IFF , ROC , SIAL

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by